News

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...
Source Reference: Vitkova M, et al "Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis: an international registry study" Neurology 2022; DOI: 10. ...
Epstein-Barr Virus Epstein-Barr virus (EBV) has long been postulated to play a role in the pathogenesis of MS, but that connection received a solid boost in 2022, when Alberto Ascherio, MD, DrPH ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
His research shows molecular changes in brain cells when a person develops multiple sclerosis (MS). But it is still unclear ...
Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...
The study also confirmed already known risk factors, including a family history of the disease, an infection with the Epstein-Barr virus and being overweight or obese as a child or adolescent.
"Regulatory T cells (Treg cells) play a crucial role in maintaining immune homeostasis. As such, Immuthera’s and PolTREG’s delivery of Tregs offers hope for curing or controlling autoimmune diseases, ...
Scientiam Pharma has disclosed new 6-aminophenanthridine derivatives acting as Epstein-Barr nuclear antigen 1 (EBNA-1) inhibitors reported to be useful for the treatment of Epstein-Barr virus ...
Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.
While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...
Multiple sclerosis cannot be completely prevented, and certain risk factors — such as age, sex, and family history — cannot be modified. However, changing your diet and lifestyle may help ...